The tripeptide glycyl-prolyl-glycine amide does not affect the early steps of the human immunodeficiency virus type 1 replication

J. Su, M. H. Naghavi, A. Jejcic, P. Horal, Y. Furuta, Y. P. Wu, S. L. Li, W. W. Hall, L. Goobar-Larsson, B. Svennerholm, A. Vahlne*

*Corresponding author for this work

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

To determine whether the peptide glycyl-prolyl-glycine amide (GPG-NH2) corresponding to a conserved motif in the tip of the third hypervariable region of gp120 affected the early events in the human immunodeficiency virus type 1 (HIV-1) replication. Design/Methods: Glycyl-prolyl-glycine amide was tested for its effect on HIV-1 adsorption, co-receptor usage, proviral DNA synthesis, messenger RNA (mRNA) synthesis and splicing, translation, tat/TAR transactivation, and virus protease activity. Results: Glycyl-prolyl-glycine amide did not appear to affect the early events of the virus replication. HIV-1 having glycine-leucine-glycine instead of GPG in the V3 loop and the mutants deleted of the GPG motif were still inhibited by the peptide. Glycyl-prolyl-glycine-NH2 had no discernible effect on any of the other steps in the virus replication cycle tested. The only effect observed was an increased sodium dodecyl sulfate polyacrylamide amide gel electrophoresis mobility of gp160/120 at high concentrations of GPG-NH2. Conclusions: The tripeptide GPG-NH2 is a nontoxic compound that inhibits the replication of HIV-1 by an apparently new mode of action.

Original languageEnglish (US)
Pages (from-to)8-15
Number of pages8
JournalJournal of Human Virology
Volume4
Issue number1
StatePublished - Feb 17 2001

Keywords

  • Anti-HIV compound
  • Anti-retrovirals
  • GPG-NH
  • Glycyl-prolyl-glycine amide
  • HIV-1
  • Peptide
  • Tripeptide

ASJC Scopus subject areas

  • Virology

Fingerprint Dive into the research topics of 'The tripeptide glycyl-prolyl-glycine amide does not affect the early steps of the human immunodeficiency virus type 1 replication'. Together they form a unique fingerprint.

  • Cite this

    Su, J., Naghavi, M. H., Jejcic, A., Horal, P., Furuta, Y., Wu, Y. P., Li, S. L., Hall, W. W., Goobar-Larsson, L., Svennerholm, B., & Vahlne, A. (2001). The tripeptide glycyl-prolyl-glycine amide does not affect the early steps of the human immunodeficiency virus type 1 replication. Journal of Human Virology, 4(1), 8-15.